Skip to main content
. Author manuscript; available in PMC: 2019 Mar 1.
Published in final edited form as: Diabetes Obes Metab. 2017 Sep 27;20(3):549–555. doi: 10.1111/dom.13106

Fig. 1.

Fig. 1

C-peptide concentrations after bolus injection in the presence of somatostatin to block endogenous insulin (and C-peptide) secretion (Panel A). Kinetics of C-peptide (Panel B) where [CP]1 and [CP]2 are C-peptide concentrations in the accessible and peripheral compartments respectively; k01, k12, k21 are kinetic parameters while ISR represents the insulin secretion rate and [CP]blood is the C-peptide concentration sampled from the peripheral circulation.